PHARMACOGENOMICS TESTING SERVICES

DNA strand for Precision Medicine

PHARMACOGENOMICS TESTING SERVICES

Genetic diagnostic testing

As a pioneer in precision medicine translational research, Dr. Broeckel’s team has been proudly providing innovative and high-quality genetic diagnostic testing since 2009.

With our 10+ years of hands-on experience in precision medicine and robust laboratory infrastructure, we offer a wide range of PGx testing services to meet the unique needs of each customer. Whether you need a Whole Pharmacogenomics Scan (WPSTM) for your research or clinical program, a targeted genotyping panel for a specific population, a tailored solution developed with next-generation sequencing (NGS), or a cutting-edge genotyping platform, we have the right solution for you.

Scientists performing genetic diagnostic testing

WPS

Our flagship service, WPS is the most comprehensive PGx testing platform available on the market in terms of the number of genes and variants that can be tested. Utilizing leading-edge technologies and highly sophisticated informatic analysis, we can analyze 4,627 markers within nearly 1,200 PGx genes of a patient with a single, one-time test.

COMPREHENSIVE

WPS’ comprehensiveness is particularly valuable when:

  • multiple genes contribute to the drug response of interest
  • diagnosing patients from ethnically diverse populations
  • discovering new genes for adverse drug reaction (ADR) susceptibility  

SCALABLE

WPS allows customers to incrementally build their precision medicine program by beginning with one or multiple medical conditions or focusing on a particular group of patients and then integrating additional gene/drug combinations into their prescribing decisions.

 

CUSTOMIZABLE

Customers can choose the genes/drugs combinations that provide the best value to their patients with the WPS Four-Tier System.

We work closely with our customers to create a customized clinical report that aligns with their medical practice.  View our highly customizable WPS clinical report.

The PGx genes tested by WPS are selected based on the peer-reviewed clinical evidence manually curated by PharmGKB. Learn more about the WPS gene/drug pairs and clinical evidence.

Targeted panels investigating CEP72, NUDT15 and TPMT genes

Our CNT (CEP72, NUDT15, and TPMT) and NT (NUDT15 and TPMT) panels are comprehensive PGx panels investigating all clinically relevant variants of three critical genes – CEP72, NUDT15, and TPMT – to guide dosing and reducing toxicities of thiopurines and vincristine. All patients receiving thiopurines and/or vincristine with concerns about toxicity should be tested.

Testing for single gene –NUDT15 – is also available. Contact us for more information.

Tailored solution and consulting services

As the leader in precision medicine translational research and a forerunner in preemptive clinical PGx, our team offers unique expertise for custom panel development and PGx consulting services to meet your organization’s unique needs.  

Contact us to discuss your research or clinical projects.

NGS service

Leveraging our decades of research experience and substantial expertise on various NGS technologies, our team of experts are uniquely positioned to offer tailored PGx end-to-end solutions, including but are not limited to, testing, analysis, interpretation, and reporting to our customers. 

If you are seeking a knowledgeable laboratory with substantial experience on various NGS platforms, RPRD is the right partner for you.

Contact us to discuss your needs.

How to Order a Test

Learn how easy it is to order a test.